Eric Anthony Nepute alias Dr. Cellular Scare

Eric Anthony Nepute is not licensed or approved by Missouri State Board of Chiropractic Examiners to advertise Cold hands and feet are a potential diagnostic flag for a serious underlying condition beyond Raynaud's. as within their scope of practice.

Cold hands and feet are a potential diagnostic flag for a serious underlying condition beyond Raynaud's.

Supports

Cold hands and feet are clinically recognized as potential indicators of a range of systemic diseases beyond primary Raynaud’s phenomenon. Multiple guideline and review sources on Raynaud’s emphasize that secondary Raynaud’s and other causes of cold extremities can reflect serious underlying conditions such as connective tissue diseases (systemic sclerosis, SLE, mixed connective tissue disease), vasculitis, large-vessel occlusive disease, paraproteinemias, and hypothyroidism, and therefore recommend structured evaluation for underlying disease when red flags are present.^{[18][16][14][20]} Cold extremities can also be a manifestation of hypothyroidism; classic clinical descriptions of myxedema note dry, cold skin of the hands and feet as part of the typical hypothyroid picture, supporting that persistent cold extremities may signal clinically important endocrine disease.^[3] Vascular and hematologic conditions such as cold agglutinin disease associated with lymphoplasmacytic lymphoma can present with cold-induced acral cyanosis, ischemia, and tissue necrosis of the hands and feet after cold exposure, illustrating that cold extremities may be the presenting clue to serious blood and lymphoid malignancy.^[5] Educational and clinical materials for Raynaud’s and cold extremities also highlight that markedly cold or asymmetric hands or feet, especially with color change, ulceration, or neurologic features, warrant urgent evaluation for serious vascular disease, autoimmune disease, or hematologic pathology beyond benign Raynaud’s.^{[16][11][14][13][15][19]}

Contradicts

There is limited high-quality evidence (e.g., randomized trials or large prospective cohorts) establishing that cold hands and feet alone, in the absence of other symptoms or exam findings, are a strong or specific diagnostic flag for serious disease. Most guidance documents and reviews treat cold extremities (including Raynaud-like symptoms) as a nonspecific symptom that is very common and often benign, especially in primary Raynaud’s, and emphasize context, associated features, and investigations rather than viewing cold extremities per se as a reliable diagnostic marker of serious pathology.^[16][18][20] Primary Raynaud’s phenomenon itself is considered common and typically benign, with low rates of progression to systemic connective tissue disease; guidelines therefore distinguish it from secondary Raynaud’s by the presence of additional red flags such as late onset, severe/asymmetric attacks, digital ulcers, abnormal nailfold capillaries, or positive autoimmune serology, indicating that cold extremities without such features are not, by themselves, regarded as a strong warning sign of serious disease.^{[16][11][14][18]} General clinical resources on cold hands and feet describe many non-serious causes such as normal response to cold, low BMI, medications, or mild autonomic or peripheral nerve dysfunction, reinforcing that while cold extremities can be associated with serious conditions, they are neither sensitive nor specific as a diagnostic flag on their own and often do not reflect dangerous disease.^[13][15]

Mainstream view

The mainstream medical view is that cold hands and feet are a common, usually nonspecific symptom most often due to benign primary Raynaud’s phenomenon or normal vasoconstrictive responses to cold, but they can also represent an important early clue to serious underlying disease when accompanied by other concerning features. Contemporary reviews and guidelines on Raynaud’s phenomenon and cold-induced vasomotor symptoms recommend that clinicians assess pattern (symmetry, triggers, color changes), onset age, tissue injury (ulcers, necrosis), and associated systemic signs (skin thickening, arthralgia, dyspnea, neurologic symptoms) and perform targeted labs and imaging when secondary causes are suspected.^{[16][18][20][14]} Serious conditions that may present with or include cold extremities include systemic sclerosis, SLE, other connective tissue diseases, vasculitis, large-vessel peripheral arterial disease, hematologic disorders such as paraproteinemia and cold agglutinin disease, endocrine disease such as hypothyroidism, and other systemic illnesses, and guidelines for Raynaud’s explicitly list many of these as secondary causes.^{[18][3][5][14][16][20]} Thus, mainstream practice is to treat persistent or atypical cold hands and feet—especially if unilateral/asymmetric, painful, associated with color changes, ulcers, systemic symptoms, or abnormal examinations—as a potential flag that warrants evaluation for serious underlying disease, while recognizing that isolated cold extremities in an otherwise well person are most often benign and not, by themselves, diagnostic of serious pathology.^{[16][11][13][15]}

In their own wordsWatch sourceArchived copy

“Cold hands and feet? Most people write it off as Raynaud’s and move on. But that symptom might be your body waving a flag for something bigger.”

Rule: RSMo § 331.010(1)

Eric Anthony Nepute is not licensed or approved by Missouri State Board of Chiropractic Examiners to advertise Supporting the body at the cellular level is a treatment that guarantees real healing. as within their scope of practice.

Supporting the body at the cellular level is a treatment that guarantees real healing.

Supports

There is substantial evidence that some specific, well‑defined interventions can promote healing by acting on cellular processes (for example, low‑level laser/photobiomodulation, hyaluronic acid–based treatments, mesenchymal stem cells, platelet‑rich plasma, and other regenerative approaches), but none of these data claim that generic “supporting the body at the cellular level” as a broad concept guarantees healing of all conditions.^[14][22][25] Systematic reviews of cell‑based and regenerative therapies for nonhealing wounds show improved healing rates in certain chronic wound populations, indicating that targeted cellular therapies can meaningfully facilitate tissue repair in specific, controlled clinical contexts.^[14][22][25] Reviews of wound healing from a cellular perspective emphasize that modulating inflammation, angiogenesis, and extracellular matrix remodeling at the cellular level is central to tissue repair, further supporting the idea that some treatments work by beneficial cellular support in defined situations.^[14]

Contradicts

No high‑quality evidence or guidelines support the absolute claim that “supporting the body at the cellular level” as a generic strategy is itself a treatment that guarantees real healing across diseases and patients.^{[19][20][23][24]} Critical reviews of alternative or unproven therapies repeatedly note that broad, vaguely defined concepts such as “cellular detoxification,” “energy” or “quantum” healing, and similar claims lack controlled trial evidence and cannot replace evidence‑based conventional treatments, especially for serious conditions.^{[19][20][23][24]} Systematic reviews and meta‑analyses of regenerative and cellular therapies show benefit only in specific indications, with variable effect sizes, limitations in study quality, and no 100% response rates; they never claim guaranteed healing for all recipients.^[14][22][25] Major evidence‑based discussions of complementary and alternative medicine stress that such modalities cannot be relied on as stand‑alone curative treatments and that their benefits, when present, are condition‑specific and often modest rather than universal or guaranteed.^{[19][20][23][24]}

Mainstream view

The mainstream medical and scientific view is that healing is a complex, probabilistic biological process influenced by disease type, severity, comorbidities, and treatment timing, and no intervention can guarantee healing in every case.^[14][22][25] Modern therapies may act at the cellular and molecular levels—for example, by modulating inflammation, promoting angiogenesis, or stimulating cell proliferation—but these mechanisms translate into improved outcomes only in specific, evidence‑defined indications and still with a risk of nonresponse or complications.^[14][22][25] Evidence‑based practice therefore relies on condition‑specific randomized trials, systematic reviews, and clinical guidelines, and rejects broad, absolute claims that any generic “cellular support” approach will universally or reliably cure disease or ensure healing.^{[19][20][23][24]}

In their own wordsWatch sourceArchived copy

“Support your body at the cellular level, and real healing follows.”

Rule: RSMo § 331.010(1)